HRTX Q1 2021 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M-21.2% YoY

Gross Profit

$11M54.0% margin

Operating Income

-$52M-260.3% margin

Net Income

-$53M-262.8% margin

EPS (Diluted)

$-0.58

QoQ Revenue Growth

-2.8%

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$43M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$311M

Total Liabilities

$115M

Stockholders' Equity

$196M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$25M	-21.2%
Gross Profit	$11M	$15M	-26.8%
Operating Income	-$52M	-$53M	+1.2%
Net Income	-$53M	-$52M	-2.0%

Revenue Segments

C I N V A N T I

$19M93%

S U S T O L

$2M8%